Team:NYMU-Taipei/Project/Enter
From 2013.igem.org
Line 25: | Line 25: | ||
<div style="clear:both;"></div> | <div style="clear:both;"></div> | ||
- | === | + | ===Why encapsulation?=== |
+ | The host immune system imposes a great threat on our engineered E.coli. Besides we have to transported our engineered E.coli in the bees through bees’ digest system, which may contain many kinds of digestive solution with variable pH value that do harm to our engineered E.coli. | ||
- | + | To solve this problem, we have to cover the E.coli with a membrane. And encapsulation is an easy way to reach the goal. Comparing to other approaches, cell encapsulation is easy to manipulate. So we choose cell encapsulation as the approach to cover the E.coli. | |
- | === | + | ====Material==== |
- | + | [[Image:NYMU_TAIPEI_alginateacid.png|thumb|300px|right|Structure of alginate polymer. α-L-guluronate sugar residues is shown on the left and β-D-mannuronate on the right side.<br> Source: http://en.wikipedia.org/wiki/Alginate]] | |
+ | There are many different biomaterial for cell encapsulation. Among those biomaterial, we choose alginate as our encapsulation material for its abundance, excellent biocompatibility and biodegradability properties. | ||
+ | |||
+ | ==Products—Bee.coli== | ||
+ | |||
+ | We successfully encapsulated the engineered E.coli( E.coli with GFP gene), and controlled its size between 10 to 200nm. Then we tried to transfer the engineered E.coli into bees midgut by adding some beads into their food. The experiment result indicate that the engineered E.coli have made into the bees’ midgut successfully. | ||
+ | |||
+ | After we proved that microencapsulation of E.coli could be sent into midgut through bees’ digestion system, we came up with an idea that we can create a drug-like product which is the mixture of sugar and microencapsulation of engineered E.coli. So we mixed the solution of microencapsulation with sugar cube and dry it. Then, we create the drug powder which can cure CCD. | ||
+ | [[Image:NYMU_TAIPEI_product.jpg|thumb|300px|right|The sugar cube with microencapsulation of E.coli on it. ]] | ||
Revision as of 17:30, 27 September 2013
Contents |
Introduction
In this part, the main purpose is to send Bee. coli into bees and make sure it can survive in the midguts. Therefore, we chose MG1655 as the chassis of our circuit, then incorporating MG1655 into alginate microcapsules, and fed bees with sugar water containing microencapsulation beads. According to our experiment, it could successfully transport the engineered Bee. coli into the bees’ midgut.
Background
Why did we choose MG1655
- The main reason we want to choose one of the substrain, MG1655, of E. coli K-12 strain as our carrier is E. coli K-12 strain exists in the midgut's of honeybees naturally. In addition, compared to nother substrain of K-12, MG1655 was selected for having few genetic manipulations from the archetypal E. coli K-12 strain, and it has already been well-studied as well.
- The second reason for choosing E. coli K-12 strain is that what we utilize to repress the sprouting of Nosema (Mannosidase), sense the invasion of Nosema (ROS) and kill Nosema (Defensin and Abaecin) are harmful to the microbes. Notably, they are naturally produced in bees as well. Besides, the immune system of honeybee will prevent our E. kobee colonizing in the epithelial cells of guts. To solve these problems, we select MG1655 which naturally exists in bees.
- Therefore, MG1655 is supposed to survive in the midguts after we send it into bees by encapsulation.
- However, the transformation efficiency of MG1655 is not as good as that of DH5 alpha, which is another substrain of K-12. On the other hand, the oxidative stress tolerance of MG1655 is much better than DH5 alpha theoretically because it's more similar to wild-type.
Why do we encapsulate Bee. coli?
The host immune system imposes a great threat on our engineered Bee. coli. Besides we have to transported our engineered Bee. coli in the bees through bees’ digest system, which may contain many kinds of digestive solution with variable pH value that do harm to our engineered Bee. coli.
To solve this problem, we have to cover the Bee. coli with a membrane. And encapsulation is an easy way to reach the goal. Comparing to other approaches, cell encapsulation is easy to manipulate, so we choose cell encapsulation as the approach to cover Bee. coli.
There are many different biomaterial for cell encapsulation. Among those biomaterial, we choose alginate as our encapsulation material for its abundance, excellent biocompatibility and biodegradability properties.
Why encapsulation?
The host immune system imposes a great threat on our engineered E.coli. Besides we have to transported our engineered E.coli in the bees through bees’ digest system, which may contain many kinds of digestive solution with variable pH value that do harm to our engineered E.coli.
To solve this problem, we have to cover the E.coli with a membrane. And encapsulation is an easy way to reach the goal. Comparing to other approaches, cell encapsulation is easy to manipulate. So we choose cell encapsulation as the approach to cover the E.coli.
Material
File:NYMU TAIPEI alginateacid.png There are many different biomaterial for cell encapsulation. Among those biomaterial, we choose alginate as our encapsulation material for its abundance, excellent biocompatibility and biodegradability properties.
Products—Bee.coli
We successfully encapsulated the engineered E.coli( E.coli with GFP gene), and controlled its size between 10 to 200nm. Then we tried to transfer the engineered E.coli into bees midgut by adding some beads into their food. The experiment result indicate that the engineered E.coli have made into the bees’ midgut successfully.
After we proved that microencapsulation of E.coli could be sent into midgut through bees’ digestion system, we came up with an idea that we can create a drug-like product which is the mixture of sugar and microencapsulation of engineered E.coli. So we mixed the solution of microencapsulation with sugar cube and dry it. Then, we create the drug powder which can cure CCD.
Experiment
Comparison of DH5 alpha and MG1655
We transform red fluorescent protein into MG1655 and DH5 alpha, then spreading on the LB plates. After cultured at 37 degree for 16 hours, we calculated the number of colonies and found the transformation efficiency of DH5 alpha is about 100-fold higher than MG1655.
DH5 alpha | MG1655 |
---|---|
Oxidative stress tolerance of MG1655
To know the oxidative stress tolerance of MG1655, we test the susceptibility to H2O2 in MG1655.
Survival test
- MG1655 cells were cultivated at 37 ˚C until the optical density (OD600) of the medium became 0.4~0.6
- The culture was equally dispensed (1 ml each) into sample tubes, and then cells were treated with various concentrations of H2O2 (final concentrations were as follows: 10μM, 50μM, 100μM, 500μM, 1 mM, 5mM, 10mM, 50mM and 100mM) at 37 ˚C for 60 min
- Testing the OD of each samples
- Doing serial dilution on samples by mixing fresh LB medium with samples
- 20μl of the diluted sample was spread out on a LB plate (amp-) and incubated at 37 ˚C (overnight)
Result and discussion
Susceptibility to H2O2 in MG1655 shown in OD | Susceptibility to H2O2 in MG1655 shown in colonies |
---|---|
From these charts, the oxidative stress tolerance of MG1655 is higher than 5mM, and epithelial cells is only 0.05mM. In the other words, the tolerance to ROS of MG1655 is over 100-fold higher than cells in midgut. Therefore, MG1655 will survive even in the stress environment in the midgut.
Treated with 100mM H2O2 diluted 104times | Treated with 50mM H2O2 diluted 104times | Treated with 10mM H2O2 diluted 105times | Treated with 5mM H2O2 diluted 105times | Treated with 1mM H2O2 diluted 106times |
---|---|---|---|---|
Treated with 500μM H2O2 diluted 106times | Treated with 100μM H2O2 diluted 107times | Treated with 50μM H2O2 diluted 107times | Treated with 10μM H2O2 diluted 107times | Treated with 0μM H2O2 diluted 107times |
Comparison table of MG1655 and DH5 alpha
Comparison | MG1655 | DH5 alpha |
---|---|---|
Strain | K12 | K12 |
Genotype | F-, lambda-, rph-1 | -fhuA2 lac(del)U169 phoA glnV44 Φ80' lacZ(del)M15 gyrA96 recA1 relA1 endA1 |
Characteristics | Similar to wild-type | Designed for transformation |
Transformation efficiency | >1x108cfu/μg | >1x106cfu/μg |
Oxidative stress tolerance | <0.1mM | >5mM |
Encapsulation
We carried out an experiment to see if microencapsulation of Bee. coli can really help our engineered Bee. coli enter bees’ midguts. We assume that only when engineered E .coli protected by the alginate membrane, it can be transported to bees’ midguts.
We tried to create microencapsulation of E. coli. Cell Encapsulation is technically achieved by dropping a mixture of cells and liquid alginate into a calcium chloride solution which solidifies the droplets, transforming them into the hydrogel beads. We should control beads’ size within the range of 20~100μm to ensure the beads can be intake by bees. We use a machine, which can help us achieve this goal.
Next, we separated our bees into three categories, which is fed with sugar mixed with microencapsulation beads of E. coli, sugar mixed with E. coli without encapsulation and sugar only. The E. coli is engineered with GFP gene, so we could find it easily under microscope. After three days, we pulled out the bees’ midguts and see if there is any engineered E. coli with GFP. As we expected, E. coli only exited in the midgut of those who had intake sugar mixed with microencapsulation beads of E.coli.
Outcome
We selected MG1655 as the chassis of our circuit, then successfully finding a way which can avoid the threat of immune system and ensure that Bee. coli won't spread into the environment to transport Bee. coli into bees. Besides, once our chassis entered the midguts of bees, it is able to survive and fight against Nosema. We mixed the solution of microencapsulation beads with sugar powder and dried it. That's what we called CCD-curing powder.